Chargement en cours...

A stochastically curtailed single-arm phase II trial design for binary outcomes

Phase II clinical trials are a critical aspect of the drug development process. With drug development costs ever increasing, novel designs that can improve the efficiency of phase II trials are extremely valuable. Phase II clinical trials for cancer treatments often measure a binary outcome. The fin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Biopharm Stat
Auteurs principaux: Law, Martin, Grayling, Michael J., Mander, Adrian P.
Format: Artigo
Langue:Inglês
Publié: 2022
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614398/
https://ncbi.nlm.nih.gov/pubmed/35077268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2021.2009498
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!